Hypertension is a major risk factor for cerebrovascular disease and stroke, and a leading contributor to Alzheimer's disease and dementia. Thus, hypertension has an enormous negative impact on the brain. Hypertension-induced changes and end-organ damage to vascular muscle underlie many forms of cerebrovascular disease with diverse consequences. Angiotensin II (Ang II) plays a fundamental role during hypertension, promotes atherosclerosis, and contributes to vascular disease in the presence of many cardiovascular risk factors. The cerebral circulation is particularly sensitive to the detrimental effects of Ang II. A major barrier to progress in preventing cerebrovascular disease has been our limited understanding of endogenous molecules that protect the brain from vascular disease. Preliminary data generated in collaboration with Project 1 suggest that the transcription factor peroxisome proliferator-activated receptor-y (PPARy) plays a major protective role in the cerebral circulation. Using novel mouse models to define cell-specific mechanisms, the overall goal is to examine the role of PPARy In smooth muscle in the cerebral circulation under normal conditions and in Ang Il-dependent models of disease. Two major endpoints related to vascular muscle will be studied - regulation of vascular tone and inward remodeling.
Aim 1 examines the hypothesis that PPARy in smooth muscle affects regulation of vascular tone and protects against Ang ll induced vascular dysfunction.
Aim 1 will also determine if vascular dysfunction following interference with PPARy is mediated by oxidative stress and/or rho kinase and whether increased expression of wild-type PPARy or expression of a constitutively active form of PPARy protects against Ang ll-induced vascular dysfunction.
Aim 2 examines the hypothesis that PPARy in smooth muscle protects against inward remodeling and hypertrophy in resistance vessels in vivo and examines mechanisms involved. Preliminary data support these Alms and suggest that interference with PPARy in vascular muscle mimics effects of Ang II in cerebral blood vessels. Thus, mechanistic studies will be performed in resistance vessels supplying brain where the negative impact of hypertension is great and where our preliminary data suggest PPARy normally plays a prominent protective role. This highly collaborative Project fits well with Program-wide themes including mechanisms of cardiovascular protection and cell-specific effects of PPARy.
Hypertension is a major risk factor for cerebrovascular disease and stroke but also a leading contributor to the vascular component of Alzheimer's disease and dementia. The goal of these studies is to define endogenous mechanisms that contribute to and protect against vascular disease in the brain during hypertension. Such insight may lead to improved therapeutic approaches to prevent or slow the progression of cerebrovascular disease.
|Doddapattar, Prakash; Jain, Manish; Dhanesha, Nirav et al. (2018) Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice. Arterioscler Thromb Vasc Biol 38:500-508|
|Hu, Xiaoming; De Silva, T Michael; Chen, Jun et al. (2017) Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke. Circ Res 120:449-471|
|De Silva, T Michael; Hu, Chunyan; Kinzenbaw, Dale A et al. (2017) Genetic Interference With Endothelial PPAR-? (Peroxisome Proliferator-Activated Receptor-?) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7. Hypertension 70:559-565|
|Dhanesha, Nirav; Doddapattar, Prakash; Chorawala, Mehul R et al. (2017) ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice. Arterioscler Thromb Vasc Biol 37:1332-1338|
|Chen, Zixin; Li, Yongjun; Yu, Hong et al. (2017) Isolation of Extracellular Vesicles from Stem Cells. Methods Mol Biol 1660:389-394|
|Shinohara, Keisuke; Liu, Xuebo; Morgan, Donald A et al. (2016) Selective Deletion of the Brain-Specific Isoform of Renin Causes Neurogenic Hypertension. Hypertension 68:1385-1392|
|Ketsawatsomkron, Pimonrat; Keen, Henry L; Davis, Deborah R et al. (2016) Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-? Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension. Hypertension 67:214-22|
|Chu, Yi; Lund, Donald D; Doshi, Hardik et al. (2016) Fibrotic Aortic Valve Stenosis in Hypercholesterolemic/Hypertensive Mice. Arterioscler Thromb Vasc Biol 36:466-74|
|Hu, Chunyan; Lu, Ko-Ting; Mukohda, Masashi et al. (2016) Interference with PPAR? in endothelium accelerates angiotensin II-induced endothelial dysfunction. Physiol Genomics 48:124-34|
|Gu, Sean X; Blokhin, Ilya O; Wilson, Katina M et al. (2016) Protein methionine oxidation augments reperfusion injury in acute ischemic stroke. JCI Insight 1:|
Showing the most recent 10 out of 288 publications